Therefore, this study utilized the SNI to create a mouse model of depression to investigate the impact of esketamine on depressive-like behaviors, the expression of PSD-95 and CRMP2 proteins, and the changes in neuronal dendritic spine plasticity in the PFC. Here, DPYSL2 is linked to depressive disorder.